A new prescription eye drop called Vuity is offering a fresh solution for people struggling with presbyopia, a common ...

Vuity offers a promising new approach to managing the effects of presbyopia, providing a convenient alternative for those looking to reduce their reliance on reading glasses. While not a cure, Vuity ...

AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company ...

The approval has been granted to Vuity (formerly AGN-190584), a once-daily eyedrop formulation of muscarinic cholinergic agonist pilocarpine developed by AbbVie's Allergen unit that is now an ...